News

SEARCH FIRM NEWS

news January 2, 2019

ATU Arguments Prevail Again in One of the “Biggest Patent Cases of 2018”

Law360 recently named the Federal Circuit’s July ruling in St. Regis Mohawk Tribe, et al. v. Mylan Pharmaceuticals Inc., et al., an appeal from the United States Patent Trial and Appeal Board, as one of the five Biggest Patent Cases of 2018.  Amin Talati Upadhye LLP attorneys submitted Comments of Amici Curiae to the PTAB […]

news December 7, 2018

Amin Talati Bolsters Trademark Practice With Addition of Two IP Leaders

Ms. Roach’s practice focuses exclusively on the trademark lifecycle. Since 2006, she has counseled clients on brand selection, portfolio strategy, trademark application prosecution, brand enforcement and defense, anti-counterfeiting measures, and trademark maintenance stretching from the United States to more than 140 countries around the world. Her extensive knowledge of trademark law helps her clients secure […]

publication September 11, 2018

Don’t let state legislation affecting food, dietary supplements fly under radar

"Don’t let state legislation affecting food, dietary supplements fly under radar". September 11, 2018. Published by Rend Al-Mondhiry in Natural Product Insider.

publication July 24, 2018

Update on the Amarin-ITC Case and the Issues at Stake

"Update on the Amarin-ITC Case and the Issues at Stake". July 24, 2018. Published by Rend Al-Mendhiry, JD and Jennifer M. Adams, JD in Regulatory Affairs Professionals Society.

news July 10, 2018

Amin Talati Upadhye, LLP Team Wins Again at the ITC in False Advertising Case

On July 9, 2018, Partners Joseph Cwik and Erin Conway earned a complete victory at the U.S. International Trade Commission (“ITC”) for the firm’s client ECI Pharmaceuticals LLC (“ECI”) when Complainants Valeant Pharmaceuticals North America LLC and Valeant Pharmaceuticals International, Inc. withdrew all allegations in their Amended Complaint against ECI and moved to terminate their […]

news April 19, 2018

Three’s Company! Al-Mondihry, Bond and Wasserman In One Article On New FTC Leadership

ATU DC’s Rend Al-Mondhiry, Katie Bond, and Ivan Wasserman have been featured in a recent article published by Natural Products Insider assessing the potential issues with dietary supplement advertising by the new FTC leadership under the Republican Administration. To read the full article, please click HERE.

news March 14, 2018

Shashank Upadhye will be Speaking at ACI’s 12th Annual Paragraph IV Disputes Conference

Shashank Upadhye will be speaking at ACI’s 12th Annual Paragraph IV Disputes conference in New York on April 23, 2018. The Paragraph IV conference is one of the biggest and most important conferences in the brand-generic drug industry. Learn more and attend the conference HERE.

news March 14, 2018

Upadhye to Be Featured Speaker at CPHI North America in April

Shashank Upadhye will be giving an Insight Briefing at the CPHI North America conference in Philadelphia on Tuesday, April 24, 2018. He will speak about IP/patent issues facing API and FDF companies, how to create defensible legal strategies, reduce costs, and improve licensing abilities. Learn more about the CPHI event HERE.

What's Now

ATU Arguments Prevail Again in One of the “Biggest Patent Cases of 2018”

Law360 recently named the Federal Circuit’s July ruling in St. Regis Mohawk Tribe, et al. v. Mylan Pharmaceuticals Inc., et al., an appeal from the United States Patent Trial and Appeal Board, as one of MORE >

see all news >